Zika Virus infection among U.S. pregnant travelers — August 2015–February 2016
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields



Publication Date Range:


Document Data


Document Type:






Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page


Zika Virus infection among U.S. pregnant travelers — August 2015–February 2016

Filetype[PDF-292.46 KB]

  • English

  • Details:

    • Journal Article:
      MMWR. Morbidity and Mortality Weekly Report
    • Description:
      After reports of microcephaly and other adverse pregnancy outcomes in infants of mothers infected with Zika Virus during pregnancy, CDC issued a travel alert on January 15, 2016, advising pregnant women to consider postponing travel to areas with active Transmission of Zika Virus. On January 19, CDC released interim guidelines for U.S. health care providers caring for pregnant women with travel to an affected area (1), and an update was released on February 5 (2). As of February 17, CDC had received reports of nine pregnant travelers with laboratory-confirmed Zika Virus disease; 10 additional reports of Zika Virus disease among pregnant women are currently under investigation. No Zika Virus–related hospitalizations or deaths among pregnant women were reported. Pregnancy outcomes among the nine confirmed cases included two early pregnancy losses, two elective terminations, and three live births (two apparently healthy infants and one infant with severe microcephaly); two pregnancies (approximately 18 weeks’ and 34 weeks’ gestation) are continuing without known Complications. Confirmed cases of Zika Virus infection were reported among women who had traveled to one or more of the following nine areas with ongoing local Transmission of Zika Virus: American Samoa, Brazil, El Salvador, Guatemala, Haiti, Honduras, Mexico, Puerto Rico, and Samoa. This report summarizes findings from the nine women with confirmed Zika Virus infection during pregnancy, including case reports for four women with various clinical outcomes. U.S. health care providers caring for pregnant women with possible Zika Virus exposure during pregnancy should follow CDC guidelines for patient evaluation and management (1,2). Zika Virus disease is a nationally notifiable condition. CDC has developed a voluntary registry to collect information about U.S. pregnant women with confirmed Zika Virus infection and their infants. Information about the registry is in preparation and will be available on the CDC website.

      Zika Virus is a mosquito-borne flaviVirus that was first isolated from a rhesus monkey in Uganda in 1947 (3). For several decades, only sporadic human disease cases were reported from Africa and Southeast Asia. In 2007, an outbreak was reported on Yap Island, Federated States of Micronesia (3), and outbreaks subsequently were reported from several Pacific Island countries (4). Local Transmission of Zika Virus was first identified in the Region of the Americas (Americas) in Brazil in May 2015 (5). Since that time, Transmission of Zika Virus has occurred throughout much of the Americas; as of February 18, a total of 32 countries and territories Worldwide have active Transmission of Zika Virus (http://www.cdc.gov/zika/geo/active-countries.html). Interim guidelines for evaluation and management of pregnant women who have traveled to areas with ongoing local Transmission of Zika Virus include offering laboratory tTesting after return from travel (2).

      During August 1, 2015–February 10, 2016, CDC received 257 requests for Zika Virus tTesting for pregnant women. Among these requests, 151 (59%) included information indicating that the woman had a clinical illness consistent with Zika Virus disease (i.e., two or more of the following signs or symptoms: acute onset of fever, rash, conjunctivitis, or arthralgia). The remaining requests did not document an illness compatible with Zika Virus disease, but reporting of symptom information might have been incomplete.

      Suggested citation for this article: Meaney-Delman D, Hills SL, Williams C, et al. Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016. MMWR Morb Mortal Wkly Rep. ePub: 26 February 2016. DOI: http://dx.doi.org/10.15585/mmwr.mm6508e1er.

    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov